Abstract

Coronavirus outbreak has influenced the global economy and everyday life of millions of people. The quest for the vaccine has already started but the limitations in productions and trial period made scientists look for alternatives, especially among naturally occurring molecules with proven biological significance. In this contribution, three recently synthesized coumarin derivatives with dopamine, norepinephrine, and octopamine were subjected to the molecular docking study and inhibitory activity determination towards SARS-CoV-2 main protease. All of the investigated molecules possess the rigid part which consists of fused heterocyclic/aromatic rings and a flexible part with electronegative atoms, therefore the study aims to provide answers about the importance of these moieties for the inhibitory activity. The results showed that coumarin derivatives with neurotransmitters have the binding energies between -39.83 and -46.26 kJ mol-1, as opposed to cinanserin (-43.56 kcal mol-1) and remdesivir (-60.08 kcal mol-1). The special emphasis in the discussion was put on the possibility of hydrogen bond formation, overall flexibility of molecules, and the position of OH groups. Based on the Fukui functions, the most active positions for electrophilic attack include aromatic OH groups of neurotransmitters and the carbonyl oxygen of coumarin. The probable nucleophilic and radical attack positions are carbon atoms of the rigid part with extended delocalization and carbonyl oxygen. The aliphatic OH groups lowered the flexibility and led to a decrease in the binding energy. Because all three derivatives passed the Lipinski rule of five, it is believed that further theoretical and experimental studies should be undertaken.

Highlights

  • The results showed that coumarin derivatives with neurotransmitters have the binding energies between -39.83 and -46.26 kJ mol-1, as opposed to cinanserin (-43.56 kcal mol-1) and remdesivir (-60.08 kcal mol-1)

  • It is interesting to observe that neurotransmitter-coumarin derivatives lose the inhibitory activity when OH group is attached to the aliphatic chain

  • Fukui functions can be used for the prediction of binding sites, especially for electrophilic and nucleophilic sites

Read more

Summary

Introduction

Human coronavirus (COVID-19) is a great threat to human health, society and economics, with more a million deaths worldwide since the beginning of spread in December 2019. The quest for vaccine will take several more months and researchers are looking for the possible inhibitors of the main protease of SARS-CoV-2. Occurring molecules and their derivatives are promising candidates for antiviral drugs, as shown recently in RSC Adv., 2020,10, 35099-35108. Three novel neurotransmitter-coumarin derivatives are investigated for the first time as possible antiviral agents by molecular docking methods and compared to cinanserin and remdesivir, as approved drugs for SARS-CoV-2. Cinanserin Inhibitor of 3-C like protease of SARS-coronavirus. Remdesivir Broad spectrum antiviral medication Approved for emergency use to threat COVID-19. Structural similarities and differences between neurotransmitter-coumarin derivatives

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.